Elizabeth Mueller

Urology Maywood, IL Female
NPI: 1871569186
Total Payments
$71,585
2024 Payments
$93.11
Companies
14
Transactions
115
Medicare Patients
1,770
Medicare Billing
$169,606

Payment Breakdown by Category

Consulting$47,941 (67.0%)
Research$12,273 (17.1%)
Travel$7,608 (10.6%)
Food & Beverage$3,762 (5.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $47,941 11 67.0%
Unspecified $12,273 20 17.1%
Travel and Lodging $7,608 21 10.6%
Food and Beverage $3,762 63 5.3%

Payments by Type

General
$59,312
95 transactions
Research
$12,273
20 transactions

Top Paying Companies

Company Total Records Latest Year
Boston Scientific Corporation $37,795 50 $0 (2024)
Astellas Pharma Global Development $13,769 25 $0 (2019)
Ferring Pharmaceuticals AS $7,312 12 $0 (2021)
Astellas Pharma Europe BV $6,825 1 $0 (2017)
UROCURE LLC $4,209 4 $0 (2019)
Allergan Inc. $388.88 3 $0 (2019)
Cook Medical LLC $378.85 7 $0 (2020)
Axonics, Inc. $230.66 4 $0 (2023)
Intuitive Surgical, Inc. $204.01 3 $0 (2022)
COLOPLAST CORP $145.39 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $93.11 1 Boston Scientific Corporation ($93.11)
2023 $128.98 2 Boston Scientific Corporation ($102.86)
2022 $456.51 7 Axonics, Inc. ($204.54)
2021 $1,604 6 Ferring Pharmaceuticals AS ($1,200)
2020 $1,058 9 Boston Scientific Corporation ($679.54)
2019 $25,687 49 Boston Scientific Corporation ($13,357)
2018 $18,607 24 Boston Scientific Corporation ($15,675)
2017 $23,949 17 Astellas Pharma Global Development ($9,286)

All Payment Transactions

115 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
02/08/2024 Boston Scientific Corporation Upsylon (Device) Food and Beverage In-kind items and services $93.11 General
Category: Upsylon_URO
09/13/2023 Axonics, Inc. Bulkamid (Device), Axonics Food and Beverage In-kind items and services $26.12 General
Category: Urology
02/16/2023 Boston Scientific Corporation Solyx SIS System (Device) Food and Beverage In-kind items and services $102.86 General
Category: Solyx_URO
12/13/2022 Intuitive Surgical, Inc. Da Vinci Surgical System (Device) Food and Beverage In-kind items and services $74.44 General
Category: SURGERY
08/24/2022 Axonics, Inc. Bulkamid (Device), Axonics Food and Beverage In-kind items and services $18.11 General
Category: Urology
06/07/2022 Medtronic, Inc. INTERSTIM (Device) Food and Beverage In-kind items and services $19.08 General
Category: Sacral Nerve Stimulation
03/29/2022 UROVANT SCIENCES INC — Food and Beverage Cash or cash equivalent $65.45 General
03/29/2022 Axonics, Inc. Axonics (Device) Food and Beverage In-kind items and services $6.17 General
Category: Urology
03/22/2022 Axonics, Inc. Bulkamid (Device), Axonics Food and Beverage In-kind items and services $180.26 General
Category: Urology
02/17/2022 Boston Scientific Corporation Solyx SIS System (Device) Food and Beverage In-kind items and services $93.00 General
Category: Solyx_URO
12/14/2021 Intuitive Surgical, Inc. Da Vinci Surgical System (Device) Food and Beverage In-kind items and services $91.57 General
Category: SURGERY
10/01/2021 Medtronic, Inc. INTERSTIM (Device) Food and Beverage In-kind items and services $24.36 General
Category: Sacral Nerve Stimulation
08/17/2021 Intuitive Surgical, Inc. Da Vinci Surgical System (Device) Food and Beverage In-kind items and services $38.00 General
Category: SURGERY
07/09/2021 Ferring Pharmaceuticals AS — Consulting Fee Cash or cash equivalent $1,200.00 General
07/07/2021 BOSTON SCIENTIFIC CORPORATION SOLYX (Device) Food and Beverage In-kind items and services $104.29 General
Category: PAIN MANAGEMENT
06/10/2021 COLOPLAST CORP Altis (Device) Food and Beverage In-kind items and services $145.39 General
Category: Women's Health
10/06/2020 Boston Scientific Corporation GENERAL - FEMALE SUI (Device) Consulting Fee Cash or cash equivalent $675.00 General
Category: FEMALE SUI
02/05/2020 Boston Scientific Corporation SOLYX (Device) Food and Beverage In-kind items and services $4.54 General
Category: PELVIC ORGAN PROLAPSE
01/06/2020 Cook Medical LLC Cook Medical Urology (Device) Travel and Lodging Cash or cash equivalent $194.79 General
Category: Urology
01/06/2020 Cook Medical LLC Cook Medical Urology (Device) Food and Beverage Cash or cash equivalent $14.82 General
Category: Urology
01/06/2020 Cook Medical LLC Cook Medical Urology (Device) Food and Beverage Cash or cash equivalent $12.07 General
Category: Urology
01/06/2020 Cook Medical LLC Cook Medical Urology (Device) Food and Beverage Cash or cash equivalent $8.12 General
Category: Urology
01/05/2020 Cook Medical LLC Cook Medical (Device) Food and Beverage Cash or cash equivalent $134.43 General
Category: Non SBU - Cook Management
01/02/2020 Cook Medical LLC Cook Medical Urology (Device) Food and Beverage Cash or cash equivalent $7.62 General
Category: Urology
01/02/2020 Cook Medical LLC Cook Medical Urology (Device) Food and Beverage Cash or cash equivalent $7.00 General
Category: Urology
123…5»

Research Studies & Clinical Trials

Study Name Company Amount Records
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Multi-center Study to Evaluate the Long-Term Safety and Efficacy of Combination of Solifenacin Succinate With Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in Subjects With Overactive Bladder Astellas Pharma Global Development $9,920 4
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, 2-Arm, Multi-center Study Comparing Tivozanib Hydrochloride in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel in the Treatment of Subjects With Locally Recurrent and/or Metastatic Triple Negative Breast Cancer Astellas Pharma Global Development $580.00 1
A RANDOMIZED, DOUBLE-BLIND, MULTI-CENTRE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ADDING MIRABEGRON TO SOLIFENACIN IN INCONTINENT OAB SUBJECTS WHO HAVE RECEIVED SOLIFENACIN FOR 4 WEEKS AND WARRANT ADDITIONAL RELIEF FOR THEIR OAB SYMPTOMS Astellas Pharma Global Development $354.56 3
A randomized, double-blind, factorial, parallel-group, active and placebo-controlled, multicenter dose-ranging study to evaluate the efficacy, safety and tolerability of six dose combinations of Solifenacin Succinate and Mirabegron compared to Mirabegron and Solifenacin Succinate monotherapies in the treatment of overactive bladder Astellas Pharma Global Development $354.56 3
A randomized, double-blind, parallel-group, active-controlled, multi-centre study to evaluate the long-term safety and efficacy of combination of Solifenacin Succinate with Mirabegron compared to Solifenacin Succinate and Mirabegron monotherapy in subjects with overactive bladder Astellas Pharma Global Development $354.56 3
A randomized, double-blind, parallel-group, placebo- and active- controlled, multicenter study to evaluate the efficacy, safety and tolerability of combinations of Solifenacin Succinate and Mirabegron compared to Solifenacin Succinate and Mirabegron monotherapy in the treatment of overactive bladder Astellas Pharma Global Development $354.56 3
Postmarketing Study of Mirabegron in Japan Long-term Add-on Therapy with Antimuscarinics in Patients with Overactive Bladder Treated with Mirabegron Astellas Pharma Global Development $354.56 3

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 375 473 $185,922 $33,756
2022 5 438 533 $208,647 $40,010
2021 6 504 636 $299,989 $56,349
2020 4 453 568 $123,483 $39,492
Total Patients
1,770
Total Services
2,210
Medicare Billing
$169,606
Procedure Codes
31

All Medicare Procedures & Services

31 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 144 203 $84,707 $15,398 18.2%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 90 90 $50,840 $8,445 16.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 77 108 $30,560 $5,301 17.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 17 19 $5,626 $1,488 26.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 15 15 $6,150 $1,448 23.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 20 26 $5,282 $1,210 22.9%
57160 Fitting and insertion of vaginal support device Facility 2023 12 12 $2,757 $465.38 16.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 133 184 $76,544 $13,791 18.0%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 80 80 $45,120 $8,605 19.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 92 124 $34,968 $5,687 16.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 43 55 $16,654 $4,906 29.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 37 37 $15,454 $4,041 26.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 28 28 $5,916 $1,796 30.4%
52000 Diagnostic exam of bladder and urethra using an endoscope Facility 2022 14 14 $11,285 $802.23 7.1%
57160 Fitting and insertion of vaginal support device Facility 2022 11 11 $2,706 $381.62 14.1%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 161 250 $103,794 $19,295 18.6%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 104 104 $58,656 $10,670 18.2%
57288 Creation of sling around bladder canal (urethra) to control leakage Facility 2021 11 11 $47,529 $6,479 13.6%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 82 108 $30,456 $5,569 18.3%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 41 41 $17,826 $5,352 30.0%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 43 55 $15,980 $5,112 32.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 24 28 $5,171 $1,908 36.9%
52000 Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope Facility 2021 21 21 $16,149 $1,276 7.9%
57160 Fitting and insertion of vaginal support device Facility 2021 17 18 $4,428 $687.06 15.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 147 206 $42,274 $12,763 30.2%
12»

About Elizabeth Mueller

Elizabeth Mueller is a Urology healthcare provider based in Maywood, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871569186.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Elizabeth Mueller has received a total of $71,585 in payments from pharmaceutical and medical device companies, with $93.11 received in 2024. These payments were reported across 115 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($47,941).

As a Medicare-enrolled provider, Mueller has provided services to 1,770 Medicare beneficiaries, totaling 2,210 services with total Medicare billing of $169,606. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.

Practice Information

  • Specialty Urology
  • Location Maywood, IL
  • Active Since 02/27/2006
  • Last Updated 04/12/2023
  • Taxonomy Code 208800000X
  • Entity Type Individual
  • NPI Number 1871569186

Products in Payments

  • GENERAL PELVIC ORGAN PROLAPSE (Device) $9,115
  • Myrbetriq (Drug) $8,321
  • UPHOLD LITE (Device) $8,026
  • Mirabegron (Drug) $7,790
  • GENERAL - PELVIC ORGAN PROLAPSE (Device) $7,513
  • GENERAL PELVIC ORGAN PROLAPSE (Device) $6,021
  • GENERAL THERAPIES (Device) $4,031
  • MIRABEGRON (Drug) $2,711
  • VESICARE (Drug) $1,773
  • THERAPIES (Device) $1,510
  • GENERAL - FEMALE SUI (Device) $738.90
  • Cook Medical Urology (Device) $244.42
  • SOLYX (Device) $236.89
  • Bulkamid (Device) $224.49
  • Da Vinci Surgical System (Device) $204.01
  • Solyx SIS System (Device) $195.86
  • BOTOX (Drug) $148.95
  • BOTOX OAB (Drug) $148.69
  • Altis (Device) $145.39
  • Cook Medical (Device) $134.43

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Urology Doctors in Maywood

Mutahar Ahmed, Md, MD

Urology — Payments: $312,946

Urology $312,946

Gopal Gupta, Md, MD

Urology — Payments: $35,040

Urology $35,040

Jeffrey Branch, Md, MD

Urology — Payments: $34,264

Urology $34,264

Michael Esposito, Md, MD

Urology — Payments: $21,408

Urology $21,408

Dr. Ahmer Farooq, D.o, D.O

Urology — Payments: $13,852

Urology $13,852

Gregory Lovallo, M.d, M.D

Urology — Payments: $12,651

Urology $12,651